XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.20.4

Stock Options | 9 Months Ended
--- | ---
Dec. 31, 2020
Stock Options |
Stock Options | NOTE 7 - STOCK OPTIONS During the nine months ended December 31, 2020 and 2019 the Company issued 100,000 stock options at an exercise price of $.29 and $.38, respectively to directors as compensation for their service. The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions outlined below. The expected volatility is based upon historical volatility of our stock and other contributing factors. The expected term is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The following inputs were used to value each option grant:
| ● | For nine months ended December 31, 2020: expected dividend yield of 0%, risk-free interest rate of 0.18%, volatility of 146.7% and an expected term of three years.
A summary of stock option activity for the nine months ended December 31, 2020 is summarized below:
|  | December 31, 2020 |
|  | Number of Options |  |  | Weighted Average Exercise Price |
Stock Options: |  |  |  |  |  |  |  |
Balance at beginning of period |  |  | 2,230,000 |  |  | $ | 0.26 |
Granted |  |  | 100,000 |  |  | $ | 0.29 |
Exercised |  |  | (440,000 | ) |  | $ | 0.06 |
Forfeited |  |  | (190,000 | ) |  | $ | 0.19 |
Balance at end of period |  |  | 1,700,000 |  |  | $ | 0.32 |
Options exercisable at end of period |  |  | 1,600,000 |  |  | $ | 0.32 |
The following table summarizes information about employee stock options outstanding at December 31, 2020:
Range of Exercise Price |  |  | Number Outstanding at December 31, 20 |  |  | Weighted Average Remaining Contractural Life |  |  | Weighted Average Exercise Price |  |  | Number Exercisable at December 31, 2020 |  |  | Weighted Average Exercise Price |
$ | .03 - $.38 |  |  |  | 1,150,000 |  |  |  | 4.3 |  |  |  | 0.23 |  |  |  | 1,050,000 |  |  |  | 0.23 |
$ | .47 - $.55 |  |  |  | 550,000 |  |  |  | 6.7 |  |  |  | 0.50 |  |  |  | 550,000 |  |  |  | 0.50 |
| * |  |  |  | 1,700,000 |  |  |  |  |  |  |  |  |  |  |  | 1,600,000 |  |  |  |  |
* Total number of options outstanding as of December 31, 2020 includes 600,000 options issued to five current and two former directors as compensation and 1,040,000 options issued to key employees that were not issued from the Plan. As of December 31, 2020 there was unrecognized expense of approximately $15,000 remaining on options currently vesting over time with approximately ten months remaining until these options are fully vested. The intrinsic value of vested options as of December 31, 2020 was approximately $121,000.

X
- References No definition available. + Details
Name: | SMDM_StockOptionsAbstract
Namespace Prefix: | SMDM_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration